EUVIMEDEUVIMED entdecken
Systematische Übersicht

Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review

Jakob Bjerager, Javad Hajari, Oliver Niels Klefter, Yousif Subhi, Miklos Schneider

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-02983-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Ophthalmology, 2024. Verfasst von Jakob Bjerager und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Rigshospitalet Glostrup, Valdemar Hansens Vej 1-23, 2600, Glostrup, Denmark. Hauptthemen laut MEDLINE: Ranibizumab, Endophthalmitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To review the risk of endophthalmitis in same-day bilateral anti-VEGF injections. METHODS: We searched 12 literature databases for studies on the risk of endophthalmitis after same-day bilateral intravitreal anti-VEGF injections. Data extraction was made independently by two authors and discussed afterward until reaching consensus. RESULTS: Seventeen studies were included with a total of 138,478 intravitreal anti-VEGF injections (69,239 bilateral injections sessions) given in at least 7579 patients. In total, 33 cases of endophthalmitis had occurred, and no cases were bilateral. The incidence of endophthalmitis ranged from 0 to 0.53% per intravitreal injection across studies. CONCLUSIONS: We suggest that clinicians can consider same-day treatment of both eyes of patients in need of bilateral intravitreal anti-VEGF injection therapy, but larger studies are needed to quantify the exact risk of endophthalmitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RanibizumabEndophthalmitisHumansAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor AIntravitreal InjectionsRetrospective StudiesIncidence

Stichwörter der Autor:innen

Adverse eventAnti-VEGFBilateralEndophthalmitisInjectionIntravitrealRiskSame-daySame-sessionSystematic review

Substanzen

RanibizumabAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, Rigshospitalet Glostrup, Valdemar Hansens Vej 1-23, 2600, Glostrup, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Ophthalmology, Rigshospitalet Glostrup, Valdemar Hansens Vej 1-23, 2600, Glostrup, Denmark. miklos.schneider@regionh.dk.
  • Department of Ophthalmology, Semmelweis University, Budapest, Hungary. miklos.schneider@regionh.dk.

Zitieren

APA

Bjerager, J., Hajari, J., Klefter, O. N., Subhi, Y., & Schneider, M. (2024). Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review. International Ophthalmology. https://doi.org/10.1007/s10792-024-02983-4

Vancouver

Bjerager J, Hajari J, Klefter ON, Subhi Y, Schneider M. Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review. International Ophthalmology. 2024. doi:10.1007/s10792-024-02983-4

BibTeX
@article{Bjerager2024,
  author = {Bjerager, Jakob and Hajari, Javad and Klefter, Oliver Niels and Subhi, Yousif and Schneider, Miklos},
  title = {Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-02983-4}
}
Kostenlos starten →